首页> 外国专利> A METHOD FOR OBTAINING A VACCINE AGAINST THE DIFFERENT PATHOGENIC SEROTYPES OF GROUP B NEISSERIA MENINGITIDIS

A METHOD FOR OBTAINING A VACCINE AGAINST THE DIFFERENT PATHOGENIC SEROTYPES OF GROUP B NEISSERIA MENINGITIDIS

机译:一种获得针对B型猪奈瑟氏球菌不同病原性血清型的疫苗的方法

摘要

pA method is provided for obtaining a vaccine against the different pathogenic serotypes of group B Neisseria meningitidis characterized by starting from live microorganisms of any one of the known pathogenic serotypes of the B group without inactivation, from which the extractation of the vesicles of the outer membrane and the protein antigenic complex of 65 - 95 KD molecular weight is carried out using detergent, enzyme and ultrasound combined in the treatment. The resulting product, after treatment to eliminate the nucleic acids, is purified by a dissociating treatment with detergent, ultrasonic bath and column chromatography. The multi-antigenic material so obtained is purified to obtain the protein antigenic complex of 65 - 95 KD molecular weight for HPLC chromatography (TSK 3000 SWG column) or affinity chromatography with monoclonal antibodies, or hydrophobicity chromatography, or ionic exchange chromatography or a combination of any one of them. The protein antigenic complex is then added to the fraction that contains the vesicles by ultrasound treatment so that it will be anchored on then, in a proportion of 15 por cent +/- 3. The capsulr polysaccharide is also added, in a proportion of 1.1 - 1.4 with respect to the protein and the adjuvant in a relation ranging from 2 - 100 mcg/protein mcg. The different components ot the mixture may be sterilized by cobalt 60 inonizing radiations with doses from 5 - 25 Kgy and a temperature between 1 - 4 grade C before preparing the mixture or the resulting mixture may be sterilized by this procedure./p[EP0301992A2]
机译:提供一种获得针对B组脑膜炎奈瑟氏球菌的不同病原血清型的疫苗的方法,其特征在于从B组的任何一种已知病原血清型的活微生物开始而不失活,从中提取B超的囊泡外膜和分子量为65-95 KD的蛋白质抗原复合物是通过使用去污剂,酶和超声波联合处理而进行的。在处理以消除核酸之后,通过用去污剂,超声浴和柱色谱的解离处理来纯化所得产物。如此获得的多抗原材料经过纯化,以获得分子量为65-95 KD的蛋白质抗原复合物,用于HPLC色谱(TSK 3000 SWG色谱柱)或与单克隆抗体的亲和色谱,或疏水性色谱或离子交换色谱或以下方法的组合他们中的任何一个。然后通过超声处理将蛋白质抗原复合物添加到包含囊泡的级分中,以便随后将其以15%+/- 3的比例锚定在其上。还以1.1的比例添加胶囊多糖。 -关于蛋白质和佐剂的1.4,范围为2-100mcg /蛋白质mcg。在制备混合物之前,可通过用60-25 Cogy剂量和1-4 C级温度对60号钴进行电离辐射来对混合物中的不同成分进行灭菌。 [[ EP0301992A2]

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号